Home About Us Industry Report Store Resources Contact us

Intramedullary Nail Market Research Report 2024

Intramedullary Nail Market Global Industry Analysis And Forecast (2024- 2032) By Type (Long Gamma Nail [LGN], Trochanteric Femoral Nail [TFN], Intertroch/Subtroch Nail [ITST]), Material (Titanium and Stainless Steel), Application (Femoral Fracture, Tibial Fracture), End User (Hospitals & Ambulatory Surgical Centers and Specialty/Orthopedic Clinics) And Region

0/5
( 0 votes )

Report ID: 386

Categories: Healthcare

Format :

Summary TOC Segmentation Methodology

Global Intramedullary Nail Market Synopsis

The Global Intramedullary Nail Market was worth USD 789.7 Million in 2023. As such, the forecast is that the market is expected to reach USD 1565.51 Million by 2032 with a CAGR of 7.9% over the period from 2024 to 2032.

An intramedullary rod, also known as an intramedullary nail (IM nail) inter-locking nail or Küntscher nail (without proximal or distal fixation), is a metal rod forced into the medullary cavity of a bone. IM nails have long been used to treat fractures of long bones of the body.

  • Intramedullary nails are metal rods surgically inserted into the medullary canal of long bones to stabilize fractures. This market is driven by the increasing prevalence of musculoskeletal conditions requiring fixation surgeries. Key factors contributing to market growth include rising road accidents, sports injuries, and an aging population. The global intramedullary nail market is segmented based on product type, material type, indication, age group, end user, and region.
  • While the market is experiencing significant growth, challenges such as high costs, potential complications, and regional variations in healthcare infrastructure and access to advanced surgical techniques persist. However, advancements in nail design, materials, and surgical techniques are expected to address these challenges and drive market growth.
  • The intramedullary nail market is highly competitive, with key players focusing on product innovation, research and development, and strategic partnerships. The market is dominated by established players, but emerging players are making inroads through the introduction of innovative products and cost-effective solutions.

Top Key Players Involved Are:        

"Stryker, B. Braun Melsungen AG, Zimmer Biomet, Smith+Nephew, Johnson & Johnson, Orthopaedic Implant Company, Orthofix Holdings, Inc., Wright Medical Group N.V., Advanced Orthopaedic Solutions, Aysam Ortopedi & Tibbi Cihazlar, MEDIN, a.s., GPC Medical USA, Inc. and Other Active Players."

Global Intramedullary Nail Market Trend Analysis

Increasing Prevalence Of Musculoskeletal Conditions:

  • Intramedullary nails, surgically inserted rods used to stabilize long bone fractures, have become indispensable in orthopedic surgery. The growing prevalence of musculoskeletal conditions is a key factor driving the demand for these medical devices.
  • One significant contributor to this trend is the aging population. As people live longer, they are more likely to experience age-related conditions such as osteoporosis, which weakens bones and increases the risk of fractures. Additionally, the increasing number of elderly individuals engaged in physical activities, including sports and exercise, can also lead to a higher incidence of musculoskeletal injuries.
  • Moreover, the rising rates of accidents, both traffic and workplace-related, have contributed to the demand for intramedullary nails. These accidents often result in fractures that require surgical intervention. The increasing urbanization and industrialization in many parts of the world have further exacerbated this trend.

Technological Advancements in 3D Printing  Creates an Opportunity for the Global Intramedullary Nail Market

  • 3D printing technology is revolutionizing the medical device industry, offering significant opportunities for the intramedullary nail market. One of the most promising advancements is the ability to create highly customized implants tailored to individual patient anatomy. By using patient-specific CT scans, 3D printing can produce intramedullary nails that perfectly fit the patient's bone structure, leading to improved surgical outcomes and reduced risk of complications.
  • Another significant opportunity lies in the development of biocompatible materials for 3D-printed implants. Researchers are exploring the use of biodegradable polymers and metal alloys that can integrate seamlessly with bone tissue, promoting faster healing and reducing the need for secondary surgeries to remove implants. Additionally, 3D printing can facilitate the creation of complex geometries and intricate designs that were previously difficult or impossible to achieve with traditional manufacturing methods. This opens up new possibilities for the development of intramedullary nails with enhanced biomechanical properties and improved fixation capabilities.

Global Intramedullary Nail Market Segment Analysis:

The Global Intramedullary Nail Market is Segmented into Type, Material, Application, End- Users, and Region.

By Type, the Long Gamma Nail segment is expected to dominate the market during the forecast period.

  • The long gamma nail (LGN) segment is poised to dominate the intramedullary nail market, driven by several factors. LGNs are highly versatile and can be used to treat a wide range of femoral fractures, including proximal, shaft, and distal fractures. This versatility makes them a preferred choice for surgeons, reducing the need for multiple types of nails.
  • LGNs are designed to provide superior stability and biomechanical strength, ensuring optimal fracture healing. Their unique locking mechanisms and distal interlocking features enhance rotational and translational stability, minimizing the risk of implant failure.
  • Advancements in LGN technology have led to the development of more anatomically contoured nails, improving patient comfort and reducing the risk of soft tissue irritation. Additionally, innovations in surgical techniques and instrumentation have simplified the insertion and removal of LGNs, reducing surgical time and improving patient outcomes.

By End-use, the Hospitals & Ambulatory Surgical Centers segment held the largest share in 2023.

  • The intramedullary nail market is primarily driven by the demand for fracture treatment in healthcare settings. Among the various end-users, hospitals and ambulatory surgical centers (ASCs) constitute the dominant segment.
  • Hospitals and ASCs are equipped with state-of-the-art infrastructure, specialized surgical suites, and experienced orthopedic surgeons capable of performing complex intramedullary nail procedures.
  • These facilities offer a comprehensive range of services, including preoperative evaluation, surgical intervention, postoperative care, and rehabilitation, ensuring a seamless patient experience.
  • Hospitals and ASCs often have established relationships with insurance providers, facilitating reimbursement for intramedullary nail procedures. This makes these facilities more accessible to patients.

Global Intramedullary Nail Market Regional Insights:

North America is Expected to Dominate the Market Over the Forecast Period

  • North America is anticipated to maintain its dominance in the intramedullary nail market throughout the forecast period. Several factors contribute to this leadership position. First, the region boasts a large and aging population, which is associated with a higher incidence of bone fractures and other musculoskeletal conditions. This demographic shift has led to a surge in demand for intramedullary nail surgeries.
  • North America has a well-developed healthcare infrastructure, with advanced medical facilities and highly skilled orthopedic surgeons. This robust healthcare system enables efficient diagnosis, treatment, and rehabilitation for patients requiring intramedullary nail implantation. Additionally, the region has a strong focus on research and development in medical technology, leading to continuous advancements in intramedullary nail design and materials.
  • The North American market benefits from a favorable regulatory environment that supports the development and adoption of innovative medical devices. The region's regulatory agencies, such as the Food and Drug Administration (FDA), provide a rigorous approval process that ensures the safety and efficacy of intramedullary nails.

Global Intramedullary Nail Market Top Key Players:

  • Stryker
  • Braun Melsungen AG
  • Zimmer Biomet
  • Smith+Nephew
  • Johnson & Johnson
  • Orthopaedic Implant Company
  • Orthofix Holdings, Inc.
  • Wright Medical Group N.V.
  • Advanced Orthopaedic Solutions
  • Aysam Ortopedi & Tibbi Cihazlar
  • MEDIN, a.s.
  • GPC Medical USA, Inc., and Other Active Players.

Global Intramedullary Nail Market

Base Year:

2023

Forecast Period:

2024- 2032

Historical Data:

2017 to 2023

Market Size in 2023:

USD 789.7 Mn.

Forecast Period 2024-32 CAGR:

7.9%

Market Size in  2032:

USD 1565.51 Mn.

Segments Covered:

By Type

  • Long Gamma Nail (LGN)
  • Trochanteric Femoral Nail (TFN)
  • Intertroch/Subtroch Nail (ITST)

By Material

  • Titanium
  • Stainless Steel

By Application

  • Femoral Fracture
  • Tibial Fracture

By End- Users

  • Hospitals & Ambulatory Surgical Centers
  • Specialty/ Orthopedic Clinics

By Region

  • North America (U.S., Canada, Mexico)
  • Eastern Europe (Bulgaria, The Czech Republic, Hungary, Poland, Romania, Rest of Eastern Europe)
  • Western Europe (Germany, UK, France, Netherlands, Italy, Russia, Spain, Rest of Western Europe)
  • Asia Pacific (China, India, Japan, South Korea, Malaysia, Thailand, Vietnam, The Philippines, Australia, New-Zealand, Rest of APAC)
  • Middle East & Africa (Turkey, Bahrain, Kuwait, Saudi Arabia, Qatar, UAE, Israel, South Africa)
  • South America (Brazil, Argentina, Rest of SA)

Frequently Asked Questions

What would be the forecast period in the Global Intramedullary Nail Market research report?

The forecast period in the Global Intramedullary Nail Market research report is 2024- 2032.

Who are the key players in the Global Intramedullary Nail Market?

Stryker, B. Braun Melsungen AG, Zimmer Biomet, Smith+Nephew, Johnson & Johnson, Orthopaedic Implant Company, Orthofix Holdings, Inc., Wright Medical Group N.V., Advanced Orthopaedic Solutions, Aysam Ortopedi & Tibbi Cihazlar, MEDIN, a.s., GPC Medical USA, Inc. and Other Active Players.

What are the segments of the Global Intramedullary Nail Market?

The Intramedullary Nail Market is Segmented into Type, Material, Application, End- Users, and Region. Type the market is categorized into (Long Gamma Nail [LGN], Trochanteric Femoral Nail [TFN], Intertroch/Subtroch Nail [ITST]), Material the market is categorized into (Titanium and Stainless Steel), Application the market is categorized into (Femoral Fracture, Tibial Fracture), End User the market is categorized into (Hospitals & Ambulatory Surgical Centers and Specialty/Orthopedic Clinics). By region, it is analyzed across North America (U.S.; Canada; Mexico), Eastern Europe (Bulgaria; The Czech Republic; Hungary; Poland; Romania; Rest of Eastern Europe), Western Europe (Germany; UK; France; Netherlands; Italy; Russia; Spain; Rest of Western Europe), Asia-Pacific (China; India; Japan; Southeast Asia, etc.), South America (Brazil; Argentina, etc.), Middle East & Africa (Saudi Arabia; South Africa, etc.).

What is the Global Intramedullary Nail Market?

An intramedullary rod, also known as an intramedullary nail (IM nail) inter-locking nail or Küntscher nail (without proximal or distal fixation), is a metal rod forced into the medullary cavity of a bone. IM nails have long been used to treat fractures of long bones of the body.

How big is the Global Intramedullary Nail Market?

The Global Intramedullary Nail Market was worth USD 789.7 Million in 2023. As such, the forecast is that the market is expected to reach USD 1565.51 Million by 2032 with a CAGR of 7.9% over the period from 2024 to 2032.

Select Licence Type

Single User

US$ 3200

Corporate User

US$ 4500

Excel Datapack

US$ 1500

Yearly Membership/Subscription

Connect with our sales team

Why AkViS Intelligence LLP

100%

Customer
Satisfaction

24x7+

Availability - we are always
there when you need us

200+

Fortune 50 Companies trust
AkViS Intelligence LLP

80%

of our reports are exclusive
and first in the industry

100%

more data
and analysis

1000+

reports published
till date